This article was originally published in The Gray Sheet
Executive SummaryE-health procurement portal announces a $12 mil. round of venture financing from New Enterprise Associates. The company is looking to deploy its e-commerce platform to more than 2,000 health care facilities by year-end through exclusive contracts with providers HealthSouth and the National Association of Community Health Centers. The company registered for a $131 mil. initial public offering on March 21 (1"The Gray Sheet" April 17, p. 12)
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.